GlassScriptPhysician profile
Theodore Cisu
NPI 1891285417
$6,697.47
in general payments reported to CMS, 2019-2025
34 companies · $1,438 in 2025
The $1,438 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.47 · 2020: $107 · 2022: $645 · 2023: $2,775 · 2024: $1,644 · 2025: $1,438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,169 · Travel and Lodging: $634 · Gift: $34.34 · Entertainment: $19.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,168.85 |
| Travel and Lodging | $633.84 |
| Gift | $34.34 |
| Entertainment | $19.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,347.74 | 2023 | Da Vinci Surgical System |
| Boston Scientific Corporation | $802.86 | 2020-2025 | Spaceoar Vue System - 10ml, Axonics, General - Erectile Dysfunction |
| Karl Storz Endoscopy-America | $730.59 | 2022-2025 | N.A., Hopkins, Hd-View |
| Urogen Pharma, INC. | $384.06 | 2023-2025 | Jelmyto |
| Pfizer INC. | $326.86 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $290.51 | 2023-2024 | Gemtesa, Orgovyx |
| Abbvie INC. | $282.42 | 2023-2025 | Lupron Depot, Botox |
| Dendreon Pharmaceuticals LLC | $211.19 | 2024-2025 | Provenge |
| Axonics, INC. | $202.81 | 2023-2024 | Axonics |
| Endo USA, INC. | $193.20 | 2024-2025 | Xiaflex, Aveed |
| Accord Healthcare, INC. | $181.17 | 2023-2025 | |
| Progenics Pharmaceuticals, INC. | $178.72 | 2023-2025 | Pylarify |
| Ambu INC. | $156.19 | 2023-2025 | |
| Olympus America INC. | $155.70 | 2022 | |
| Endo Pharmaceuticals INC. | $149.97 | 2023-2024 | Xiaflex, Aveed |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Photocure INC | $126.90 | 2023-2025 | Cysview |
| Janssen Biotech, INC. | $106.90 | 2024-2025 | Erleada |
| Teleflex LLC | $99.21 | 2024 | Urolift |
| Astellas Pharma US INC | $97.22 | 2023-2024 | Xtandi, Myrbetriq |
| Allergan, INC. | $88.47 | 2019 | |
| Ferring Pharmaceuticals INC. | $74.22 | 2025 | Adstiladrin |
| Novartis Pharmaceuticals Corporation | $71.78 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.70 | 2024-2025 | |
| Tempus Ai, INC | $55.18 | 2024-2025 | Xt Cdx |
| Coloplast Corp | $54.14 | 2024-2025 | |
| Abc Home Medical Supply, INC. | $45.89 | 2025 | |
| Laborie Medical Technologies Corp. | $43.15 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Ge Healthcare | $37.40 | 2025 | |
| Hollister Incorporated | $33.46 | 2023-2024 | Vapro Pocket, Infyna Chic, Onli |
| Procept Biorobotics Corporation | $28.63 | 2025 | |
| Medtronic, INC. | $23.74 | 2025 | Interstim |
| Immunitybio, INC. | $23.48 | 2025 | |
| Provepharm INC. | $19.97 | 2024 | Bludigo |
| Cycle Pharmaceuticals INC | $17.04 | 2025 | Venxxiva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Cisu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.